Anavex Life Sciences Corp.

News & Events

Press Releases

In The Media

1. ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Long-Term Investors to Contact the Firm

   GlobeNewswire JUN 16, 2025 6:38 PM EDT
   PHILADELPHIA, June 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it...
   READ ARTICLE

2. Anavex Life Sciences to Participate at Upcoming Healthcare Conferences

   GlobeNewswire MAY 14, 2025 7:30 AM EDT
   NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or ...
   READ ARTICLE

3. Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update

   GlobeNewswire MAY 13, 2025 7:30 AM EDT
   Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 13, 2025 (GLOBE...
   READ ARTICLE

4. Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025

   GlobeNewswire MAY 6, 2025 7:30 AM EDT
   NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or ...
   READ ARTICLE

5. Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

   GlobeNewswire MAY 1, 2025 7:30 AM EDT
   Study ANAVEX3-71-SZ-001 successfully completes enrollment with a total of 71 participants ...
   READ ARTICLE

6. Anavex Life Sciences to Participate in The Citizens Life Sciences Conference

   GlobeNewswire APR 30, 2025 7:30 AM EDT
   NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” o...
   READ ARTICLE

7. Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

   GlobeNewswire APR 23, 2025 7:30 AM EDT
   NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” o...
   READ ARTICLE

8. Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East

   GlobeNewswire APR 21, 2025 7:30 AM EDT
   NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” o...
   READ ARTICLE

9. Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease

   GlobeNewswire APR 5, 2025 11:30 AM EDT
   ATTENTION-AD trial data through 192 weeks presented at AD/PD TM 2025 Conference ...
   READ ARTICLE

10. Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

    GlobeNewswire MAR 31, 2025 7:30 AM EDT
    NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” o...
    READ ARTICLE